YN

Yogesh Nemichand Patni

Active Director Director DIN 02185397
DIN 02185397 First appointment May 2008 Primary industry Healthcare
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since May 2008
Shareholding value •••• Premium profile

About Yogesh Nemichand Patni

Data last updated:

Yogesh Nemichand Patni is a Director at Jainson Pharmaceuticals Private Limited (since 2008). The company operates in Healthcare. Jainson Pharmaceuticals Private Limited reported revenue of ₹39.5 Lakh (FY 2025).

DIN 02185397
Primary Designation Director
Industry Healthcare
First Appointment 06 May 2008
Oldest Company Age 30 yrs
Largest company Jainson Pharmaceuticals Private Limited · ₹39.5 Lakh (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director06 May 20081996₹39.5 Lakh (FY 2025)Active

Board colleagues of Yogesh Nemichand Patni

Directorship timeline

Open interactive timeline →
Jainson Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Yogesh Nemichand Patni

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Yogesh Nemichand Patni

Yogesh Nemichand Patni currently holds 1 directorship: Jainson Pharmaceuticals Private Limited (Director, since 06 May 2008, revenue ₹39.5 Lakh (FY 2025)).

Yogesh Nemichand Patni was first appointed on 06 May 2008 as Director at Jainson Pharmaceuticals Private Limited.

The current boards of Yogesh Nemichand Patni's companies include Nemichand Motilal Patni (Jainson Pharmaceuticals Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available